Skip to content

Clinical trials

Phase 1/2 Nasopharyngeal Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Nasopharyngeal Neoplasms Phase: Phase 1/2 Country / region: United States Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20071
20131
20151
20192
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated3
Recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Atara Biotherapeutics1
Avenzo Therapeutics, Inc.1
Cullinan Therapeutics Inc.1
Duke University1
Hope Cancer Institute, Inc.1
Marengo Therapeutics, Inc.1
Ohio State University Comprehensive Cancer Center1
Sanjiv Sam Gambhir1
Takeda1
University of Illinois at Chicago1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Nasopharyngeal Neoplasms11
Head and Neck Neoplasms5
Salivary Gland Neoplasms5
Hypopharyngeal Neoplasms4
Laryngeal Neoplasms4
Mouth Neoplasms4
Oropharyngeal Neoplasms4
Squamous Cell Carcinoma of Head and Neck4
Carcinoma3
Carcinoma, Non-Small-Cell Lung3

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.